Yokohama, Japan

Manabu Hisamoto

This inventor holds 1 USPTO granted patent. Top assignee: Fujifilm Medical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manabu Hisamoto. Retrieved from https://idiyas.com/inventor/manabu-hisamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manabu Hisamoto and Drug Traceability Innovation.

Introduction

Manabu Hisamoto is an inventor associated with Yokohama, Japan, and Fujifilm Medical Co., Ltd. His work includes a patented system designed to improve the traceability of packaged drugs.

Latest Patents

Hisamoto is credited with one patent: “Drug management system, cloud server, drug packaging apparatus, drug package auditing apparatus, packaging bag, and drug management method.” The invention uses unique identification information on each drug package. A dispensing pharmacy’s packaging apparatus prints the identifier on a label and attaches it to the packaging bag. The pharmacy uploads information about the packaged drugs to a cloud server, which manages the information in association with the identifier. Authorized inquiries using the identifier can then help trace the packaged drugs.

Career Highlights

The patent describes a coordinated approach involving drug packaging equipment, labels, and cloud-based information management. By linking package-level identifiers with drug information, the system is intended to support traceability across the handling of packaged medications.

Collaborations

Masanobu Takashima and Yoshiaki Ishimaru are identified as Hisamoto’s coworkers. The patent’s described system also involves dispensing pharmacies and cloud-server infrastructure.

Conclusion

Manabu Hisamoto’s patent focuses on connecting uniquely identified drug packages with centrally managed information, offering a technology-based approach to improving medication traceability.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…